These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 14552653)

  • 21. Serotonin and noradrenaline reuptake inhibitors in animal models of pain.
    Mochizucki D
    Hum Psychopharmacol; 2004 Oct; 19 Suppl 1():S15-9. PubMed ID: 15378668
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serotonergic mechanisms and the new antidepressants.
    Stahl SM
    Psychol Med; 1993 May; 23(2):281-5. PubMed ID: 8332642
    [No Abstract]   [Full Text] [Related]  

  • 23. [Consequences of the monoaminergic systems cross-talk in the antidepressant activity].
    Tritschler L; Gaillard R; Gardier AM; David DJ; Guilloux JP
    Encephale; 2018 Jun; 44(3):264-273. PubMed ID: 29801770
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacology of antidepressants: selectivity or multiplicity?
    Westenberg HG
    J Clin Psychiatry; 1999; 60 Suppl 17():4-8; discussion 46-8. PubMed ID: 10446734
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Noradrenaline and serotonin reuptake inhibition as clinical principles: a review of antidepressant efficacy.
    Humble M
    Acta Psychiatr Scand Suppl; 2000; 402():28-36. PubMed ID: 10901156
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synergistic benefits of serotonin and noradrenaline reuptake inhibition.
    Nelson JC
    Depress Anxiety; 1998; 7 Suppl 1():5-6. PubMed ID: 9597344
    [No Abstract]   [Full Text] [Related]  

  • 27. Clinical evidence and potential neurobiological underpinnings of unresolved symptoms of depression.
    Trivedi MH; Hollander E; Nutt D; Blier P
    J Clin Psychiatry; 2008 Feb; 69(2):246-58. PubMed ID: 18363453
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combining norepinephrine and serotonin reuptake inhibition mechanisms for treatment of depression: a double-blind, randomized study.
    Nelson JC; Mazure CM; Jatlow PI; Bowers MB; Price LH
    Biol Psychiatry; 2004 Feb; 55(3):296-300. PubMed ID: 14744472
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Physical recovery is part of remission].
    Krankenpfl J; 2004; 42(3-4):110. PubMed ID: 15311907
    [No Abstract]   [Full Text] [Related]  

  • 30. Pharmacological principles of antidepressant efficacy.
    Schatzberg AF
    Hum Psychopharmacol; 2002 Jun; 17 Suppl 1():S17-22. PubMed ID: 12404665
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The dual-action hypothesis: does pharmacology matter?
    Shelton RC
    J Clin Psychiatry; 2004; 65 Suppl 17():5-10. PubMed ID: 15600376
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical and biochemical effects of catecholamine depletion on antidepressant-induced remission of depression.
    Miller HL; Delgado PL; Salomon RM; Berman R; Krystal JH; Heninger GR; Charney DS
    Arch Gen Psychiatry; 1996 Feb; 53(2):117-28. PubMed ID: 8629887
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The neuropharmacology of serotonin and noradrenaline in depression.
    Nutt DJ
    Int Clin Psychopharmacol; 2002 Jun; 17 Suppl 1():S1-12. PubMed ID: 12369606
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The other face of depression, reduced positive affect: the role of catecholamines in causation and cure.
    Nutt D; Demyttenaere K; Janka Z; Aarre T; Bourin M; Canonico PL; Carrasco JL; Stahl S
    J Psychopharmacol; 2007 Jul; 21(5):461-71. PubMed ID: 17050654
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Noradrenergic approaches to antidepressant therapy.
    Gorman JM; Sullivan G
    J Clin Psychiatry; 2000; 61 Suppl 1():13-6. PubMed ID: 10703758
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Depression and pain: novel clinical, neurobiological and psychopharmacological data].
    Jaracz J; Rybakowski J
    Psychiatr Pol; 2005; 39(5):937-50. PubMed ID: 16358593
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analgesic effects of serotonergic, noradrenergic or dual reuptake inhibitors in the carrageenan test in rats: evidence for synergism between serotonergic and noradrenergic reuptake inhibition.
    Jones CK; Eastwood BJ; Need AB; Shannon HE
    Neuropharmacology; 2006 Dec; 51(7-8):1172-80. PubMed ID: 17045620
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Dual acting reuptake inhibitors in the treatment of depression and pain].
    Hajak G
    Dtsch Med Wochenschr; 2006 Dec; 131 Suppl 8():S280-3. PubMed ID: 17139587
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of painful physical symptoms in the treatment of Japanese patients with melancholic major depressive disorder: A prospective cohort study.
    Sekine A; Hozumi S; Shimizu T
    Psychiatry Res; 2016 Aug; 242():240-244. PubMed ID: 27294798
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison between noradrenergic and serotonergic medications using the social adjustment scale: is drive enhancement necessary for recovery of social functioning?
    Luty SE; Joyce PR; Mulder RT
    J Psychopharmacol; 2001 Dec; 15(4):257-64. PubMed ID: 11769819
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.